Results 91 to 100 of about 7,681 (214)

Safety, tolerability and risk benefit analysis of tiotropium in COPD

, 2008
Yuji Oba, Tareq Zaza, Danish M ThameemUniversity of Missouri, School of Medicine, Division of Pulmonary, Critical Care and Environmental Medicine, Columbia, MO, USAAbstract: COPD is a chronic disease and, like many other chronic diseases, there is no ...
Yuji Oba, Tareq Zaza, Danish M Thameem
core  

Dual bronchodilation with tiotropium/olodaterol further reduces activity-related breathlessness versus tiotropium alone in COPD

, 2020
The 3-min constant speed shuttle test (CSST) was used to examine the effect of tiotropium/olodaterol compared with tiotropium at reducing activity-related breathlessness in patients with chronic obstructive pulmonary disease (COPD). This was a randomised,
Macesic, Hemani, AUMANN, Joseph, Hamilton, Alan, Maltais, Francois, Jin, Xidong, Nadreau, Eric, O'Donnell, Denis E., Kirsten, Anne-Marie   +7 more
core   +1 more source

Tiotropium w terapii POChP

, 2015
Exacerbations of chronic obstructive pulmonary disease (COPD) have a negative effect on the clinical course and outcome of the disease thus causing considerable social and economic burden.
Kuna, Piotr, Kupczyk, Maciej; Division of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Poland, Szepiel, Paweł   +2 more
core   +1 more source

Alternative mechanisms for tiotropium [PDF]

, 2020
a b s t r a c t Tiotropium is commonly used in the treatment of chronic obstructive pulmonary disease. Although largely considered to be a long-acting bronchodilator, its demonstrated efficacy in reducing the frequency of exacerbations and preliminary ...
K Racké, B K Rubin, T Welte, P J Barnes, E D Bateman, R Gosens, P V Dicpinigaitis, J A Nadel, N J Gross, M Pfeifer, S Rennard, K F Rabe, I Wessler   +12 more
core  

Suppression of IL-8 production from airway cells by tiotropium bromide in vitro

, 2011
Isao Suzaki1, Kazuhito Asano2, Yusuke Shikama3, Taisuke Hamasaki1, Ayako Kanei1, Harumi Suzaki11Department of Otorhinolaryngology, School of Medicine, Showa University, Tokyo, Japan; 2Division of Physiology, School of Nursing and Rehabilitation Sciences,
Suzaki I, Hamasaki T, Asano K, Kanei A, Suzaki H, Shikama Y   +5 more
core  

Long-term safety of tiotropium delivered by Respimat® SoftMist™ Inhaler: patient selection and special considerations

, 2016
Ching Kuo Tan, Gui Quan Say, James B Geake Department of Respiratory Medicine, Lyell McEwin Hospital, Elizabeth Vale, SA, Australia Abstract: Tiotropium bromide is a long-acting inhaled muscarinic antagonist used in patients with chronic respiratory ...
Tan CK, Geake JB, Say GQ
core  

Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study

, 2016
Rüdiger Sauer,1 Michaela Hänsel,2 Roland Buhl,3 Roman A Rubin,4 Marcel Frey,5 Thomas Glaab2,3 1Lung Centre Ulm, Ulm, Germany; 2Boehringer Ingelheim Pharma GmbH & Co.
Frey M, Rubin RA, Hänsel M, Buhl R, Glaab T, Sauer R   +5 more
core  

Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies

International Journal of COPD, 2018
Craig LaForce,1 Eric Derom,2 Ulrich Bothner,3 Isabel M Kloer,3 Matthias Trampisch,4 Roland Buhl5 1NC Clinical Research, Raleigh, NC, USA; 2Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium; 3Pharmacovigilance, Boehringer ...
LaForce C, Derom E, Bothner U, Kloer IM, Trampisch M, Buhl R   +5 more
doaj  

Sequential comparison of tiotropium to high-dose ipratropium in patients with chronic obstructive pulmonary disease in a practice setting

, 2009
Umair Gauhar, Mark Dransfield, J Allen D CooperPulmonary Section, Birmingham Veterans Affairs Medical Center and Division of Allergy, Pulmonary and Critical Medicine University of Alabama at Birmingham, AL, USAObjective: To determine the effect of ...
J Allen D Cooper, Umair Gauhar, Mark Dransfield   +2 more
core  

Tiotropium Respimat® improves physical functioning in chronic obstructive pulmonary disease

, 2010
Heike Rau-Berger1, Harald Mitfessel2, Thomas Glaab11Medical Affairs Germany, Respiratory Medicine, Boehringer Ingelheim Pharma GmbH and Co. KG, Ingelheim; 2Pulmonology Practice, Remscheid, GermanyAim: This observational study with tiotropium Respimat&
Harald Mitfessel, Thomas Glaab, Heike Rau-Berger   +2 more
core